Current FDA directives for promoting public health

Journal Article · Mon Mar 01 00:00:00 EST 1982 · Am. J. Hosp. Pharm.; (United States)

OSTI ID:6929379

Hayes, Jr, A H

The current directions of the FDA are outlined. The underlying philosophy of the FDA under the Reagan Administration is that both the private sector and the government must address the responsibilities to which they are best suited for the health-care system to work more efficiently. To facilitate this, FDA is conducting comprehensive reviews of FDA regulations and the drug-evaluation process. There are many dimensions to promoting public health, and the FDA alone cannot assure an adequate supply of safe and effective drugs. Innovative science and technology are needed to develop new drugs, followed by maximum potentiation (maximum good and least harm) after FDA approval. Hospital pharmacists have a role in maximizing the potential benefits of drugs through pharmacy and therapeutics committees. The current status of the pilot program for patient package inserts is described. The response at a recent hearing on the program indicates that the responsibility to protect the public health is shared by the government, health professions, industry, and the public. The FDA's campaign on sodium is based on that shared responsibility. By improving communication and building upon their common objections, both pharmacy and the FDA can do their jobs successfully.

• Research Organization: Department of Health and Human Services, Rockville, MD
• OSTI ID: 6929379
• Journal Information: Am. J. Hosp. Pharm.; (United States), Vol. 39:3
• Country of Publication: United States
• Language: English

Related Subjects

99 GENERAL AND MISCELLANEOUS//MATHEMATICS, COMPUTING, AND INFORMATION SCIENCE
62 RADIOLOGY AND NUCLEAR MEDICINE
PUBLIC HEALTH
GOVERNMENT POLICIES
ADMINISTRATIVE PROCEDURES
DRUGS
MEDICAL CENTERS
PHARMACOLOGY
PUBLIC INFORMATION
REGULATIONS
US FDA
INFORMATION
NATIONAL ORGANIZATIONS
US HEW
US ORGANIZATIONS
552000* - Public Health
550600 - Medicine